Global Oncology Academy

Understanding the Underlying Mechanisms in Myelofibrosis

ReachMD Healthcare Image

Our understanding of the pathophysiology of myelofibrosis has evolved in recent years. Here’s what we know so far.

  • Overview

    What’s the role of the JAK-STAT pathway in myelofibrosis, and what are the key genetic mutations and biomarkers we need to be aware of? Explore the pathophysiology of myelofibrosis with Dr. Charles Turck and Dr. Serge Verstovsek, Professor in the Department of Leukemia at the University of Texas MD Anderson Cancer Center.

Facebook Comments



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free